双时间点18F-FDG PET/CT体积参数对接受根治性放疗的非小细胞肺癌患者的预后价值
回顾性分析59例接受根治性放疗的非小细胞肺癌患者,于治疗前常规行双时间点18F-FDG PET/CT,评估原发灶及原发灶联合淋巴结的SUVmax、MTV、TLG及其变化率对预后的预测价值。多因素分析显示,TLG-T及ΔTLG-TN是局部控制率的显著预测因子,TLG-T及ΔTLG-T是疾病特异性生存的显著预测因子;ΔTLG百分比较低与较差的局部控制和疾病特异性生存相关。
要点
- TLG-T及ΔTLG-TN是局部控制率的独立预后因素。
- TLG-T及ΔTLG-T是疾病特异性生存的独立预后因素。
- ΔTLG-T<41.0%或ΔTLG-TN<32.0%与较差的局部控制和疾病特异性生存相关。
核心结论
- TLG和ΔTLG是接受根治性放疗的非小细胞肺癌患者的显著预后因素,尤其ΔTLG相对较低者局部控制率和疾病特异性生存较差。
研究设计与样本
- 回顾性分析2010年4月至2017年4月连续接受根治性放疗的非小细胞肺癌患者,共118例中59例符合纳入标准。
诊断标准与关键数值
- 多因素分析显示,局部控制率的显著预测因子为TLG-T和ΔTLG-TN;疾病特异性生存的显著预测因子为辅助化疗、治疗反应、TLG-T和ΔTLG-T;ΔTLG-T<41.0%和ΔTLG-TN<32.0%与较差的局部控制率和疾病特异性生存相关;SUVmax和MTV对局部控制率和疾病特异性生存均不是显著预测因子。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE. The purpose of this study is to assess the effectiveness of the volumetric parameters of dual-time-point imaging (DTPI) with 18F-FDG PET (DTPI FDG PET) in predicting the prognosis of patients with non-small cell lung cancer (NSCLC) treated with definitive radiation therapy (RT). MATERIALS AND METHODS. The records of consecutive patients who received definitive RT for NSCLC from April 2010 to April 2017 were retrospectively reviewed. Pretreatment DTPI FDG PET images were routinely obtained as part of the PET/CT examination. The maximum standardized uptake value (SUVmax), metabolic tumor volume (MTV), and total lesion glycolysis (TLG) of the primary tumor (SUVmax-T, MTV-T, and TLG-T, respectively) and those of the primary tumor and lymph nodes (N) combined (SUVmax-TN, MTV-TN, and TLG-TN, respectively) were used as variables, and the percentage change in these parameters (change in SUVmax [ΔSUVmax], change in MTV [ΔMTV], and change in TLG [ΔTLG]) on DTPI FDG PET were analyzed. RESULTS. Of the 118 patients identified and reviewed, 59 met the study eligibility criteria. After a median follow-up of 23.3 months, the 3-year local control rate (LCR) and disease-specific survival rates were 53.5% and 45.0%, respectively. On multivariate analysis, significant predictors of LCR were TLG-T and change in TLG-TN (ΔTLG-TN), and significant predictors of disease-specific survival were adjuvant chemotherapy, treatment response, TLG-T, and change in TLG-T (ΔTLG-T). Low percentage changes in ΔTLG (< 41.0% for ΔTLG-T and < 32.0% for ΔTLG-TN) correlated with poor LCR and disease-specific survival. SUVmax and MTV were not significant predictors of both LCR and disease-specific survival. CONCLUSION. TLG and ΔTLG were significant prognostic factors in patients with NSCLC treated with definitive RT. In particular, a relatively low ΔTLG resulted in poor outcomes in terms of LCR and disease-specific survival.
引用
- Okazaki E, Seura H, Hasegawa Y, et al. Prognostic Value of the Volumetric Parameters of Dual-Time-Point 18F-FDG PET/CT in Non-Small Cell Lung Cancer Treated With Definitive Radiation Therapy. AJR Am J Roentgenol. 2019. PMID: 31509426. doi:10.2214/AJR.19.21376
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。